"T1: hypointense"
"T1 C+: no enhancement"
"T2/FLAIR: hyperintense"
"Isomorphic diffuse gliomas, at times also referred to as isomorphic neuroepithelial tumours, are not yet included in the 2021 WHO classification of CNS tumours and are loosely contained within the diagnosis of diffuse astrocytoma MYB or MYBL1 altered despite different epidemiology and DNA-methylation profile 1,2."
"GFAP: positive 2"
"ATRX-expression: retained"
Expected headings
"Immunohistochemisty"
"Grading"
"MYBL1 alterations (e.g. gene fusions) 2; or"